1 July 2015
Headquartered in London,
INOVYN has pro-forma sales of more than €3 billion,
with 4,300 employees and assets across 18 sites
in Belgium, France, Germany, Italy, Norway, Spain, Sweden
and the UK. Governance of the Joint Venture
is equally split between the partners.
INOVYN market share by key products:
• General Purpose Vinyls – #1 in Europe
• Specialty Vinyls – #2 in Europe
• Chlorine – #1 in Europe
• Caustic Soda – #1 in Europe
• Caustic Potash – #1 in Europe
• Chloromethanes – #1 in Europe
• Epichlorohydrin – #1 in Europe (merchant market)
• Allyl Chloride – #1 in Europe
• Chlorinated Paraffins – #1 in Europe
DETAILS
announce the start-up of their Joint Venture
a world-class competitive player in
chlorovinyls, following European Commission approval.
The finalized terms of the Joint Venture agreement
remain materially unchanged from those announced
in June last year.
Solvay received upon closing
an upfront cash payment of €150 million – subject to
customary adjustments such as actual working capital levels.
In addition to contributing their entire European chlorovinyl business
Solvay has transferred liabilities estimated at €260 million
into the Joint Venture.
In three years’ time, Solvay will exit INOVYN and
receive an additional, performance-based payment targeted
to be €280 million, with a minimum of €95 million.
Thereafter, INEOS will be the sole owner of the business.
INOVYN PRESS CONTACT
Craig Welsh
Direct line: + 44 (0) 1928 511528
Email: craig.welsh@inovyn.com
WWW.CHEMWINFO.COM BY KHUN PHICHAI
